Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page
- Check5 days agoChange DetectedSteatotic Liver Disease was added and Fatty Liver Disease was removed from the page’s disease terminology, updating the labeling to reflect the standardized umbrella term for fat-related liver conditions and affecting how the study is categorized and searched within liver disease terms.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This appears to be a version update and does not indicate changes to the study content.SummaryDifference0.0%

- Check27 days agoChange DetectedA new revision tag 'Revision: v3.6.2' appears on the page, replacing the former 'Revision: v3.6.0'. This signals an update to the page's revision/version metadata.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated recruitment status to No longer looking for participants. Adjusted the Intervention/Treatment heading formatting and updated the page revision to Revision: v3.6.0, replacing the previous version.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page's revision tag was updated to v3.5.5, signaling an updated build of the page.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.5.4 was added, replacing the prior v3.5.3. This appears to be an internal platform update with no visible changes to trial data, page content, or navigation.SummaryDifference0.0%

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.